Special Issue "Updates on Veterinary Vaccines and Vaccinology"

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".

Deadline for manuscript submissions: 30 June 2024 | Viewed by 1122

Special Issue Editors

Nebraska Center for Virology and Department of Animal Science, University of Nebraska-Lincoln, Lincoln, NE 68583, USA
Interests: PRRSV; influenza; ASFV; vaccine development; viral pathogenesis
Special Issues, Collections and Topics in MDPI journals
School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, P.O. Box 830905, Lincoln, NE 68583-0905, USA
Interests: vaccine formulation; immunogenicity; efficacy; effectiveness; adjuvants
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Vaccination is the most cost-effective method for controlling infectious diseases in livestock. Mass vaccination campaigns have successfully led to the eradication of several significant diseases across various regions worldwide. The advancements in molecular biology and biotechnology have played a pivotal role in the development of modern vaccines with enhanced safety and efficacy.

This Special Issue aims to publish articles that highlight the recent advancements in the field of veterinary vaccines and vaccinology. It specifically focuses on the application of vaccines to eradicate specific veterinary pathogens within a country or region. Furthermore, the issue addresses the rational design of the next generation of vaccines, the identification of immune correlates associated with vaccine-induced protection, and the examination of the impact of vaccines on pathogen evolution.

Dr. Hiep Vu
Prof. Dr. David Scott McVey
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • vaccines
  • immune responses
  • vaccine effectiveness
  • vaccine efficacy
  • vaccine development

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


15 pages, 2937 KiB  
A Single-Dose Intramuscular Immunization of Pigs with Lipid Nanoparticle DNA Vaccines Based on the Hemagglutinin Antigen Confers Complete Protection against Challenge Infection with the Homologous Influenza Virus Strain
Vaccines 2023, 11(10), 1596; https://doi.org/10.3390/vaccines11101596 - 15 Oct 2023
Viewed by 795
The Influenza A virus of swine (IAV-S) is highly prevalent and causes significant economic losses to swine producers. Due to the highly variable and rapidly evolving nature of the virus, it is critical to develop a safe and versatile vaccine platform that allows [...] Read more.
The Influenza A virus of swine (IAV-S) is highly prevalent and causes significant economic losses to swine producers. Due to the highly variable and rapidly evolving nature of the virus, it is critical to develop a safe and versatile vaccine platform that allows for frequent updates of the vaccine immunogens to cope with the emergence of new viral strains. The main objective of this study was to assess the feasibility of using lipid nanoparticles (LNPs) as nanocarriers for delivering DNA plasmid encoding the viral hemagglutinin (HA) gene in pigs. The intramuscular administration of a single dose of the LNP-DNA vaccines resulted in robust systemic and mucosal responses in pigs. Importantly, the vaccinated pigs were fully protected against challenge infection with the homologous IAV-S strain, with only 1 out of 12 vaccinated pigs shedding a low amount of viral genomic RNA in its nasal cavity. No gross or microscopic lesions were observed in the lungs of the vaccinated pigs at necropsy. Thus, the LNP-DNA vaccines are highly effective in protecting pigs against the homologous IAV-S strain and can serve as a promising platform for the rapid development of IAV-S vaccines. Full article
(This article belongs to the Special Issue Updates on Veterinary Vaccines and Vaccinology)
Show Figures

Figure 1

Back to TopTop